Microbiologics recalled 18 units of KWIK-STIK 6-Pack on December 2, 2025. The kits may fail to recover the target microorganism Campylobacter jejuni subsp. jejuni. Patients and healthcare providers should stop using the device immediately.
Affected units may fail to recover the target microorganism Campylobacter jejuni subsp. jejuni derived from ATCC 29428.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Microbiologics Inc or your healthcare provider for instructions. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
The recalled product is the KWIK-STIK 6-Pack, Catalog Number 0325K, with UDI-DI: 30845357006463. It includes Lot Numbers: 325-120-1, 325-120-4, 325-120-6, and an additional lot added on 12/22/25: 325-119-2. These were distributed worldwide, including throughout the U.S.
The affected units may fail to recover the target microorganism Campylobacter jejuni subsp. jejuni derived from ATCC 29428. This malfunction poses a significant health risk, especially in clinical settings where accurate microbial testing is critical.
There have been no reported incidents or injuries associated with the recalled kits. The recall is classified as Class II, indicating a high risk of adverse health consequences.
Stop using the KWIK-STIK kits immediately. Follow the recall instructions provided by Microbiologics and contact your healthcare provider for further guidance.
For further information, contact Microbiologics Inc. Visit their website or call their customer service for assistance.
Get instant alerts for recalls that affect you. Free forever.
Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.
Fresenius Kabi Compounding recalled 1,057 bags of Acyclovir Sodium Injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers should cease use immediately and contact the manufacturer for guidance.
Fresenius Kabi Compounding recalled its vancomycin HCl injection on February 5, 2026, due to a lack of assurance of sterility. This Class II recall affects all lots distributed nationwide. Healthcare providers and consumers must stop using the product immediately.
Fresenius Kabi Compounding recalled 1,578 bags of vancomycin HCl injection on February 5, 2026. The company cited a lack of assurance of sterility as the reason for the recall. Healthcare providers and consumers should stop using the product immediately.
Fresenius Kabi Compounding recalled 1,410 bags of ketamine HCl injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers and consumers must stop using this product immediately.
Fresenius Kabi Compounding recalled 10,548 bags of thiamine HCl injection on February 5, 2026. The recall follows a lack of assurance of sterility, posing a high health risk. Affected products include several lots expiring between February and May 2026.
Pro Numb Tattoo Numbing Spray was recalled due to cGMP deviations. The recall affects products distributed nationwide in the USA. Consumers should stop using the spray immediately and contact Pro Numb Tattoo Numbing Spray LLC for guidance.
Pro Numb Tattoo Numbing Spray was recalled on February 2, 2026 due to cGMP deviations. The product, containing 4% lidocaine, is distributed by Pro Numb Tattoo Numbing Spray LLC. Consumers should stop using it immediately and contact the company for further guidance.